Lupus Foundation of America Medical Director Dr. Joan Merrill provides an overview of lupus and its health effects.
Developing Consensus Treatment Plans for Pediatric Lupus Nephritis
Most drugs used to treat lupus are used off-label. They were never developed for lupus and their use was never evaluated in children. Conducting clinical studies involving children can be challenging and involve many ethical considerations. Dr. Emily von Scheven of the Director of the University of California San Francisco Pediatric Rheumatology Program, discusses the development of consensus treatment plans for proliferative nephritis in juvenile systemic lupus. This study was funded in part by the Lupus Foundation of America's Michael Jon Barlin Pediatric Lupus Research Program.
Presenter: Emily von Scheven, MD
Presentation date: November 16, 2011
Dr. Richard Furie of the North Shore-Long Island Jewish Health System provides an overview of how lupus is treated.